As an entrepreneur, Diamandis has started 17 companies. He is the Co-Founder and Vice-Chairman of Human Longevity Inc. (HLI), a genomics and cell therapy-based company focused on extending the healthy human lifespan, and Co-Founder and Co-Chairman of Planetary Resources, a company designing spacecraft to enable the detection and prospecting of asteroid for fuels and precious materials.

Diamandis is a New York Times Bestselling author of two books: Abundance & BOLD. He earned degrees in Molecular Genetics and Aerospace Engineering from the MIT, and holds an M.D. from Harvard Medical School.

In Fall of 2016 the Greek Government honored Diamandis by issuing a 1.2 Euro stamp into circulation bearing his photograph.

Prior to assuming his current position with IBM, he served as the Chief Medical Information Officer and Director of Clinical Informatics for the DoD VA Interagency Program Office, where he was responsible for creating a unified Interagency Electronic Health Record for over 125,000 providers and 18 million beneficiaries worldwide.

As the former Director of the Military Health System Electronic Health Record Way Ahead Office he was responsible for overseeing the development and deployment of the next generation of the Department of Defense’s (DoD) global Electronic Health Record (EHR) system.

Dr. Weiner’s experience also included serving as the Deputy Program Manager and Chief Medical Officer for the Department of Defense’s Defense Health Information Management System where he deployed the Military Health Electronic Health Record to 74 hospitals and 250 clinics worldwide and to the White House. He also was responsible for creating the Chief Information Officer Office at the Bureau of Medicine and Surgery Navy Medicine.

As the Chief Medical Officer of the global Navy Expeditionary Combat Command, Dr. Weiner served as the senior medical officer to more than 200 medical departments supporting 40,000 Service Members worldwide. In addition to leveraging IT capabilities throughout the continuum of care his team also created and globally deployed point of injury kits that provide Service Members immediate care during trauma and in remote areas of operation. This medical work was praised by the House Appropriations Committee and has become the standard for many international medical teams.

As the Director of Ambulatory Care at Yokosuka Naval Hospital in Japan, Dr. Weiner brought significant lean six business process transformation to Japan’s busiest outpatient healthcare setting, resulting in unprecedented patient and clinician satisfaction for over 50,000 patients per month and 160 world-class healthcare providers.

He is an active member of the American College of Physicians, the American Osteopathic Association and is a former NASA Space Shuttle takeoff and landing physician. Dr. Weiner serves on the Philadelphia College of Osteopathic Medicine Alumni Board, the board of the American Medical Informatics Association as well as having served on the Health and Human Services’ Office of the National Coordinator, Health Information IT Policy Committee, helping create Meaningful Use Stage 1. He has received numerous awards from the President of the United States, for his service in the Navy, including two Meritorious Service Medals, and two Air Medals.

Holman currently works for Nathan Myhrvold at the Intellectual Ventures Laboratory, spearheading the creation of a wide variety of futuristic invention projects. These endeavors include a fission reactor powered by nuclear waste, a machine designed to suppress hurricanes, a system to reverse global warming, and a device that can shoot mosquitoes out of the sky with lasers to help eradicate malaria.

Holman has informed and lectured audiences on invention, innovation, cyber security, and the future of technology at world-renowned technology summits, including the United Nations, the World Economic Forum at Davos, The CIA, TEDx and DEF CON.

Dr. Longo’s studies focus on the fundamental mechanisms of aging in simple organisms, mice and humans. The Longo laboratory has identified several genetic pathways that regulate aging in simple organisms and reduce the incidence of multiple diseases in mice and humans. His laboratory also described both dietary and genetic interventions that could reverse the course of Diabetes and Alzheimer’s and protect cells and improve the treatment of cancer and other diseases in mammals. Dr. Longo’s most recent studies are on dietary interventions that can affect stem cell-based regeneration to promote longevity in mice and humans. The Longevity Institute in Los Angeles, directed by Dr. Longo, includes over 40 faculty members focused on topics ranging from regeneration to dietary interventions aimed at improving health and lifespan in the near future. Among the accolades received by Dr. Longo are the 2010 Nathan Shock Lecture Award from the National Institute on Aging (NIA/NIH) and the 2013 Vincent Cristofalo “Rising Star” Award in Aging Research from the American Federation for Aging Research (AFAR).

Dr. Longo is recognized as a global leader in aging and nutrition. With more than 106 peer reviewed publications in journals like Science, Nature, Cell, JAMA, Circulation, Cancer Cell, Journal of Translational Medicine, etc. He is recognized by Time Magazine, with three features in less than two years, as Longevity Guru. He is one of the most recently featured scientists by global media and news feeds. He has received in 2016 the Jubilee award by the Royal Scottish Academy.

Dr. Longo was born and raised in Genoa, Italy and received his undergraduate degree from the University of North Texas, where he majored in biochemistry with a minor in jazz performance. He received his Ph.D. in Biochemistry from the University of California, Los Angeles (UCLA) in 1997 and his postdoctoral training in the Neurobiology of Aging and Alzheimer’s Diseases at USC. He started his independent career in 2000 at the University of Southern California, School of Gerontology, one of the first and leading programs for aging research and education.

He was previously a post-doctoral fellow and faculty at the Department of Ophthalmology and Visual Sciences of Yale School of Medicine as well as former faculty at Harvard Medical School. He was a recipient of several grants, including grants from the United States Department of Defense, Research to Prevent Blindness, and the Massachusetts Lions Research Fund. His previous accomplishments and scientific achievements include: while at Harvard developed advanced laser systems for the U.S. Air Force; patented opto-electromagnetic tonometric systems and licensed it to Nestl and its pharmaceutical unit, Alcon Laboratories; worked on spectroscopy culminating with the identification of the Radiation Signature of Glucose within the mid-infrared wavelength irradiated as thermal energy from the body. He discovered the BTT, which enabled noninvasive, continuous measurement of human brain temperature. His discovery was featured in a press release by Yale University, stating that for the first time in history brain temperature has been measured noninvasively and continuously. Dr. Abreu also developed the first FDA-approved computer system for continuous temperature measurement during surgery, intensive care and general monitoring in association with ASUS Corporation. This system utilizes a micro sensor positioned on the BTT skin surface that measures brain temperature. The device renders the most accurate and true body temperature without corrective factors found in other digital and infrared thermometers. He has also developed proprietary thermal measurement systems, devices and applications based on the BTT. Dr. Abreu is a pioneer in research on brain thermal signatures and has studied brain thermodynamics for two decades and invented technologies that resulted in multiple patents. The technology Dr. Abreu created helps medical professionals, employers, coaches and individuals capture brain thermal signatures, which can be used to prevent death from high or low body temperature, and has the potential to detect and manage a host of human conditions and diseases including Alzheimers disease, Parkinsons disease, and multiple sclerosis

He heads the laboratory of regenerative medicine at the Clinical Research Center for Pediatric Hematology, Oncology and Immunology where his research interests include Hutchinson-Gilford Syndrome, new methods of cellular reprogramming, molecular mechanisms of skin and cartilage regeneration and personalized medicine in oncology. He is also the international adjunct professor at the Moscow Institute of Physics and Technology.

He is the CEO and co-founder of InSilico Medicine, Inc a Baltimore-based company utilizing Big Data analysis for aging research and drug discovery. Prior to InSilico Medicine, he co-founded the First Oncology Research and Advisory Center, a personalized medicine organization providing contract research services to oncologists interested in gene expression and activated signaling pathway analysis and predicted effectiveness of targeted drugs to improve clinical decision making. He is also the head of research at NeuroG Neuroinformatics, a neuroinformatics company developing algorithms for cost-effective EEG devices to recognize imagined visual images and delay the onset of age-related neurodegenerative diseases.

Dr. Zhavoronkov is the author of multiple peer-reviewed scientific as well as popular papers and books on the many aspects of biogerontology, aging research and aging economics including The Ageless Generation: how biomedical advances will transform the global economy published by Palgrave Macmillan.

He holds two bachelor degrees from Queen's University, a masters in biotechnology from Johns Hopkins Universtity and a PhD in physics and mathematics from the Moscow State University.

Prior academic positions include Professor of Surgery at Yale University and a military appointment as Professor of Surgery (USUHS) in the Army Medical Corps assigned to General Surgery at Walter Reed Army Medical Center. Government positions included Program Manager of Advanced Biomedical Technology at the Defense Advanced Research Projects Agency (DARPA) and Senior Science Advisor at the US Army Medical Research and Materiel Command in Ft. Detrick, Maryland and Director of the NASA Commercial Space Center for Medical Informatics and Technology Applications at Yale University. Upon completion of military career and government service he had continued clinical medicine at Yale University and University of Washington.

His undergraduate training was at Johns Hopkins University, Medical School at Hahnemann University of Philadelphia, Internship at the Cleveland Clinic, Surgical Residency at the Mayo Clinic, and a Fellowship with a Master of Surgical Research at Mayo Clinic.

He has served on the White House Office of Science and Technology Policy (OSTP) Committee on Health, Food and Safety and was also awarded the prestigious Department of Defense Legion of Merit and Department of Defense Exceptional Service medals as well as awarded the Smithsonian Laureate in Healthcare. He has been a member of numerous committees of the American College of Surgeons (ACS), currently serving on the ACS-Accredited Education Institutes (ACS-AEI). He is a Past President of the Society of American Gastrointestinal Endoscopic Surgeons (SAGES), the Society of Laparoendoscopic Surgeons (SLS), and the Society of Medical Innovation and Therapy (SMIT). He was a member of the National Board of Medical Examiners (NBME) and is currently on Board of many surgical societies and on the editorial board of numerous surgical and scientific journals, and active in a number of surgical and engineering societies.

Dr. Satava was the surgeon on the project that developed the first surgical robot, which later became the DaVinci Surgical Robot. In addition, as a government official, he funded all of the surgical robot development for the first 10 years, until commercialization became possible. For 5 years he was a member of the Advisory Board of the National Space Biomedical Research Institute (NSBRI) advising NASA in surgical robotics, advanced biometric sensing and other life science research for astronauts. Now Dr. Satava has added being continuously active in surgical education and surgical research, with more than 200 publications and book chapters in diverse areas of advanced surgical technology, including Surgery in the Space Environment, Video and 3-D imaging, Telepresence Surgery, Virtual Reality Surgical Simulation, and Objective Assessment of Surgical Competence and Training and the Moral and Ethical Impact of Advanced Medical Technologies.

During his 23 years of military surgery he has been an active flight surgeon, an Army astronaut candidate, MASH surgeon for the Grenada Invasion, and a hospital commander during Desert Storm, all the while continuing clinical surgical practice. Current research is focused on advanced technologies to formulate the architecture for the next generation of clinical Medicine, education and training.